1887

Journal of Medical Microbiology logo

Volume 58, Issue 8

Uropathogens from diabetic patients in Libya: virulence factors and phylogenetic groups of isolates Free

Abstract

Urinary tract infections (UTIs) in patients with diabetes mellitus (DM) are reported mainly from developed countries. In addition to this underreporting from developing countries, there is a lack of information pertaining to the virulence factors (VFs) and phylogenetic grouping of uropathogenic (UPEC) from DM and non-DM patients in developing countries. Between July 2005 and June 2006, urine specimens were collected from 135 DM and 164 non-DM patients, all with clinically diagnosed UTIs, attending Elkhadra Hospital and the Diabetic Center in Tripoli, Libya. Specimens were examined for different uropathogens using standard microbiological procedures. Isolated uropathogens were tested for their susceptibility to antimicrobial agents by a disc diffusion method. In addition, UPEC was grouped phylogenetically by PCR and subsequently tested for 19 VFs. Uropathogens were isolated from 77 (57 %) of the DM group and from 110 (67 %) of the non-DM group ( >0.05). was isolated from 18 (13 %) and 29 (18 %), species from 18 (13 %) and 23 (14 %), and from 12 (9 %) and 12 (7 %) of the DM and non-DM groups, respectively ( >0.05). Age, gender, education level and marital status had no significant influence on the isolation rates of different organisms from the DM group compared with the non-DM group. With very few exceptions, no differences were observed in the antimicrobial resistance profiles of uropathogens from the DM and non-DM patients. In addition, UPEC from the DM patients was significantly less virulent and was associated with phylogenetic group A, whilst UPEC from the non-DM patients was significantly more virulent and was associated with group D. The results of our surveillance of UTI infections in DM patients agree, in general, with observations reported previously from several developed countries.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): DM, diabetes mellitus , MDR, multidrug resistance , OR, odds ratio , UPEC, uropathogenic Escherichia coli , UTI, urinary tract infection and VF, virulence factor
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.007146-0
2009-08-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/8/1006.html?itemId=/content/journal/jmm/10.1099/jmm.0.007146-0&mimeType=html&fmt=ahah

References

  1. Andriole V. T. 2002; Asymptomatic bacteriuria in patients with diabetes – enemy or innocent visitor?. N Engl J Med 347:1617–1618 [CrossRef]
     [Google Scholar]
  2. Balasoiu D., Van Kessel K. C., Kats-Renaud H. J., Collet T. J., Hoepelman A. I. 1997; Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 20:392–395 [CrossRef]
     [Google Scholar]
  3. Bonadio M., Meini M., Gigli C., Longo B., Vigna A. 1999; Urinary tract infection in diabetic patients. Urol Int 63:215–219 [CrossRef]
     [Google Scholar]
  4. Bonadio M., Meini M., Spitaleri P., Gigli C. 2001; Current microbiological and clinical aspects of urinary tract infections. Eur Urol 40:439–444 [CrossRef]
     [Google Scholar]
  5. Bonadio M., Costarelli S., Morelli G., Tartaglia T. 2006; The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis 6:54–60 [CrossRef]
     [Google Scholar]
  6. Bower J. M., Eto D. S., Mulvey M. A. 2005; Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 6:18–31 [CrossRef]
     [Google Scholar]
  7. Boyd E. F., Hartl D. L. 1998; Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J Bacteriol 180:1159–1165
     [Google Scholar]
  8. Boyko E. J., Fihn S. D., Scholes D., Chen C. L., Normand E. H., Yarbro P. 2002; Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care 25:1778–1783 [CrossRef]
     [Google Scholar]
  9. Brauner A., Hylander B., Ostenson C.-G. 1988; Bacteremia with Escherichia coli in diabetic patients. Studies on bacterial virulence and host factors. Diabete Metab 14:625–628
     [Google Scholar]
  10. Calvet H. M., Yoshikawa T. T. 2001; Infections in diabetes. Infect Dis Clin North Am 15:407–421 [CrossRef]
     [Google Scholar]
  11. Clermont O., Bonacorsi S., Bingen E. 2000; Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558 [CrossRef]
     [Google Scholar]
  12. CLSI 2005 Performance Standards for Antimicrobial Susceptibility Testing ; 15th Informational Supplement, M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  13. Collee J. G., Duguid J. P., Fraser A. G., Marmion B. P. 1989 Practical Medical Microbiology , 3rd edn. Edinburgh: Churchill Livingstone;
     [Google Scholar]
  14. Drews S. J., Poutanen S. M., Mazulli T., McGeer A. J., Sarabia A., Pong-Porter S., Rzayev Y., Willey B., Green K., Low D. E. 2005; Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 43:4218–4220 [CrossRef]
     [Google Scholar]
  15. Geerlings S. E. 2008; Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int J Antimicrob Agents 31:S54–S57 [CrossRef]
     [Google Scholar]
  16. Geerlings S. E., Stolk R. P., Camps M. J., Netten P. M., Collet T. J., Hoepelman A. I. 2000a; Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 23:1737–1741 [CrossRef]
     [Google Scholar]
  17. Geerlings S. E., Stolk R. P., Camps M. J., Netten P. M., Hoekstra J. B. L., Bouter K. P., Bravenboer B., Collet J. T., Jansz A. R., Hoepelman A. I. 2000b; Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749 [CrossRef]
     [Google Scholar]
  18. Geerlings S. E., Brouwer E. C., Gaastra W., Stolk R., Diepersloot R. J., Hoepelman A. I. 2001; Virulence factors of Escherichia coli isolated from urine of diabetic women with asymptomatic bacteriuria: correlation with clinical characteristics. Antonie Van Leeuwenhoek 80:119–127 [CrossRef]
     [Google Scholar]
  19. Hansen D. S., Gottschau A., Kolmos H. J. 1998; Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control. J Hosp Infect 38:119–132 [CrossRef]
     [Google Scholar]
  20. Hu K. K., Boyko E. J., Scholes D., Scholes D., Normand E., Chen C.-L., Grafton J., Fihn S. D. 2004; Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 164:989–993 [CrossRef]
     [Google Scholar]
  21. Huang S.-H., Wass C., Fu Q., Prasadarao N. V., Stins M., Kim K. S. 1995; Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10 . Infect Immun 63:4470–4475
     [Google Scholar]
  22. Jacobson S. H., Tullus K., Wretlind B., Brauner A. 1988; Aerobactin mediated iron uptake by Escherichia coli strains causing acute pyelonephritis and bacteremia. J Infect 16:147–152 [CrossRef]
     [Google Scholar]
  23. Johnson J. R. 1991; Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128
     [Google Scholar]
  24. Johnson J. R., Brown J. J. 1998; Colonization with and acquisition of uropathogenic Escherichia coli strains as revealed by polymerase chain reaction-based detection. J Infect Dis 177:1120–1124 [CrossRef]
     [Google Scholar]
  25. Johnson J. R., Stell A. L. 2000; Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181:261–272 [CrossRef]
     [Google Scholar]
  26. Johnson J. R., Delavari P., Kuskowski M., Stell A. L. 2001; Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli . J Infect Dis 183:78–88 [CrossRef]
     [Google Scholar]
  27. Johnson J. R., Van der Schee C., Kuskowski M. A., Goessens W., Van Belkum A. 2002; Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from The Netherlands. J Infect Dis 186:1852–1856 [CrossRef]
     [Google Scholar]
  28. Johnson J. R., Kuskowski M. A., Owens K., Gajewski A., Winokur P. L. 2003; Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 188:759–768 [CrossRef]
     [Google Scholar]
  29. Johnson J. R., Kuskowski M. A., Gajewski A., Sahm D. F., Karlowsky J. A. 2004; Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000–2001. J Infect Dis 190:1739–1744 [CrossRef]
     [Google Scholar]
  30. Johnson J. R., Kuskowski M. A., O'Bryan T. T., Colodner R., Raz R. 2005; Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 49:26–31 [CrossRef]
     [Google Scholar]
  31. Jorgeensen J. H., Turnidge J. D. 2003; Susceptibility test methods: dilution and disk diffusion methods. In Manual of Clinical Microbiology , 8th edn. pp 1108–1127 Edited by Murray P. R., Baron E. J., Jorgensen J. H., Pfaller M. A., Yolken R. H. Washington, DC: American Society for Microbiology;
     [Google Scholar]
  32. Joshi N., Caputo G. M., Weitekamp M. R., Karchmer A. W. 1999; Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912 [CrossRef]
     [Google Scholar]
  33. Koneman E. W., Allen S. D., Janda W. M., Schreckenberger P. C., Winn W. C. Jr 1997 Color Atlas and Textbook of Diagnostic Microbiology , 5th edn. Philadelphia: Lippincott;
     [Google Scholar]
  34. Le Bouguenec C., Archambaud M., Labigne A. 1992; Rapid and specific detection of the pap , afa , and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 30:1189–1193
     [Google Scholar]
  35. Ludwig E. 2000; Bacteriuria in women with diabetes mellitus. Infect Urol 13:S3–S6
     [Google Scholar]
  36. Lye W. C., Chan R. K., Lee E. J., Kumarasinghe G. 1992; Urinary tract infections in patients with diabetes mellitus. J Infect 24:169–174 [CrossRef]
     [Google Scholar]
  37. Patterson J. E., Andriole V. T. 1995; Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 9:25–51
     [Google Scholar]
  38. Picard B., Garcia J. S., Gouriou S., Duriez P., Brahimi N., Bingen E., Elion J., Denamur E. 1999; The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546–553
     [Google Scholar]
  39. Pozzilli P., Leslie R. D. G. 1994; Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11:935–941 [CrossRef]
     [Google Scholar]
  40. Schubert S., Rakin A., Karch H., Carniel E., Heesemann J. 1998; Prevalence of the “high-pathogenicity island” of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun 66:480–485
     [Google Scholar]
  41. Stapleton A. 2002; Urinary tract infections in patients with diabetes. Am J Med 113:80S–84S
     [Google Scholar]
  42. Tseng C. C., Huang J. J., Ko W. C., Yan J. J., Wu J. J. 2001; Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormality. J Urol 166:1643–1646 [CrossRef]
     [Google Scholar]
  43. Tseng C. C., Wu J. J., Liu H. L., Sung J. M., Huang J. J. 2002; Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli . Am J Kidney Dis 39:744–752 [CrossRef]
     [Google Scholar]
  44. Vila J., Simon K., Ruiz J., Horcajada J. P., Velasco M., Barranco M., Moreno A., Mensa J. 2002; Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis 186:1039–1042 [CrossRef]
     [Google Scholar]
  45. Warren J. W., Abrutyn E., Hebel J. R., Johnson J. R., Schaeffer A. J., Stamm W. E. 1999; Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29:745–758 [CrossRef]
     [Google Scholar]
  46. Wilson M. L., Gaido L. 2004; Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 38:1150–1158 [CrossRef]
     [Google Scholar]
  47. Wiselka M. F. 1996; Bacterial and host factors in the pathogenesis of urinary tract infections. In Infections of the Kidney and Urinary Tract pp 8–33 Edited by Cattell W. R. New York: Oxford;
     [Google Scholar]
  48. Yamamoto S., Terai A., Yuri K., Kurazono H., Takeda Y., Yoshida O. 1995; Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 12:85–90 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.007146-0
Loading
Uropathogens from diabetic patients in Libya: virulence factors and phylogenetic groups of Escherichia coli isolates
J. Med. Microbiol. 58, 1006 (2009); https://doi.org/10.1099/jmm.0.007146-0
/content/journal/jmm/10.1099/jmm.0.007146-0
/content/journal/jmm/10.1099/jmm.0.007146-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error